Results 131 to 140 of about 5,956 (233)

Plasma leukocyte-derived extracellular vesicles are related to target vessel revascularization in off-pump coronary artery bypass grafting

open access: yes
Introduction: In multivessel coronary disease, interventional therapy is recommended to improve symptoms and survival. Inflammatory activation is postulated as one of the coronary atherosclerosis progression risk factors and prognostic indicators of ...
Jemielity, Marek   +19 more
core   +1 more source

Ten-year experience with single-vessel and multivessel reoperative off-pump coronary artery bypass grafting

open access: yes, 2008
ObjectivePatients undergoing reoperative coronary artery bypass have increased mortality and morbidity compared with those undergoing primary coronary bypass. The experience in applying off-pump techniques to coronary reoperations is limited.
Malhotra, Rajneesh   +5 more
core   +1 more source

Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double‐Blind Phase II Trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim This study aimed to evaluate its safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy in Chinese adults with T2DM and to preliminarily compare its efficacy and safety with semaglutide through multiple subcutaneous injections. Materials and Methods In this multicentre, randomised, placebo‐controlled and semaglutide‐positive‐
Ping Jin   +9 more
wiley   +1 more source

Dysregulated pathways for off-pump coronary artery bypass grafting

open access: yes, 2017
The objective of this paper was to identify dysregulated myocardial pathways with off-pump coronary artery bypass grafting (OPCABG) based on pathway interaction network (PIN)
Shu Yi-Zhu   +3 more
core   +1 more source

Cardiovascular Outcomes in a SELECT‐Like Obesity Cohort: Real‐World Insights From the Swedish AROS Database

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background In the SELECT trial, semaglutide reduced major adverse cardiovascular outcomes (MACE) in individuals with overweight or obesity and established cardiovascular disease (CVD) but without diabetes. However, real‐world cardiovascular event rates in comparable populations remain uncharacterised.
Viveca Ritsinger   +5 more
wiley   +1 more source

Diastolic dysfunction and off-pump coronary artery bypass [PDF]

open access: yesBritish Journal of Anaesthesia, 2009
M. Edsell   +3 more
openaire   +2 more sources

On-pump versus off-pump coronary artery bypass surgery in patients with preoperative anemia

open access: yes, 2015
Objectives The study objective was to evaluate the effects on early outcome and midterm survival of performing coronary artery bypass grafting with the off-pump technique in comparison with cardiopulmonary bypass (on-pump) in patients with preoperative ...
Guida P.   +9 more
core   +1 more source

What Is a Clinically Meaningful Change in Diabetes Distress? Findings for Diabetes Care and Research From the SFDT1 Cohort

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Diabetes distress (DD) is common and evolves heterogeneously over time. We aimed to estimate minimal clinically important differences (MCID) for the Problem Areas in Diabetes (PAID) scale and its sub‐dimensions and to identify predictors of worsening over 1 year in people with type 1 diabetes (PwT1D).
Dulce Canha   +10 more
wiley   +1 more source

Perioperative patency of coronary artery bypass grafting is not influenced by off-pump technique

open access: yes, 2005
Background. Some concerns have been raised about technical accuracy and quality of distal anastomoses in off-pump myocardial revascularization. (OPCAB), which could affect graft patency.Methods.
Renzulli, Attilio   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy